Literature DB >> 17340193

Structural and functional properties of antibodies to the superantigen TSST-1 and their relationship to menstrual toxic shock syndrome.

Rita Kansal1, Catherine Davis, Melanie Hansmann, Jon Seymour, Jeffrey Parsonnet, Paul Modern, Steve Gilbert, Malak Kotb.   

Abstract

Menstrual toxic shock syndrome (mTSS) is an acute febrile disease accompanied by hypotension and multiple organ involvement. Infection with Staphylococcus aureus producing the superantigen toxic shock syndrome toxin-1 (TSST-1) vaginally is necessary; however, only a small fraction of those infected with TSST-1 producing bacteria actually develop mTSS, suggesting that host factors modulate disease susceptibility. Serum antibodies to the toxin protect against development of the syndrome, but not all antibodies can neutralize the toxin. We set out to determine whether risk of developing the syndrome is related to the absence of neutralizing antibody and if antibody isotypes influence the neutralization capacity. In healthy subjects, TSST-1-binding serum antibodies were exclusively of the IgG and IgM classes; however, toxin-neutralizing capacity was correlated to the TSST-1-specific IgG1 and IgG4 antibodies (r (2)=0.88, p<0.0001 and 0.33, p<0.0086, respectively) but not with IgM antibodies. Specific IgA was not detectable. Compared to healthy matched controls who were colonized vaginally with S. aureus, IgG1 anti-TSST-1 antibodies and toxin neutralizing activity was lacking in all of the acute phases and in the majority of convalescent sera, suggesting that these patients may be incapable of generating TSST-1 neutralizing antibodies. These new findings support the hypothesis that host factors are important in the development of mTSS and that the anti-toxin isotype impacts antibody functionality.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17340193     DOI: 10.1007/s10875-007-9072-4

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.542


  32 in total

1.  Relative neutralizing activity in polyspecific IgM, IgA, and IgG preparations against group A streptococcal superantigens.

Authors:  A Norrby-Teglund; N Ihendyane; R Kansal; H Basma; M Kotb; J Andersson; L Hammarström
Journal:  Clin Infect Dis       Date:  2000-11-10       Impact factor: 9.079

2.  Tampon absorbency, composition and oxygen content and risk of toxic shock syndrome.

Authors:  S F Lanes; K J Rothman
Journal:  J Clin Epidemiol       Date:  1990       Impact factor: 6.437

Review 3.  Role of toxic shock syndrome toxin 1 in toxic shock syndrome: overview.

Authors:  P M Schlievert
Journal:  Rev Infect Dis       Date:  1989 Jan-Feb

4.  Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women.

Authors:  Jeffrey Parsonnet; Melanie A Hansmann; Mary L Delaney; Paul A Modern; Andrea M Dubois; Wendy Wieland-Alter; Kimberly W Wissemann; John E Wild; Michaelle B Jones; Jon L Seymour; Andrew B Onderdonk
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

5.  An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections.

Authors:  Malak Kotb; Anna Norrby-Teglund; Allison McGeer; Hesham El-Sherbini; M Tevik Dorak; Ayesha Khurshid; Karen Green; Jeanie Peeples; Judy Wade; Glenys Thomson; Benjamin Schwartz; Donald E Low
Journal:  Nat Med       Date:  2002-11-18       Impact factor: 53.440

6.  A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates.

Authors:  M S Bergdoll; B A Crass; R F Reiser; R N Robbins; J P Davis
Journal:  Lancet       Date:  1981-05-09       Impact factor: 79.321

7.  Toxic shock syndrome surveillance in the United States, 1980 to 1981.

Authors:  A L Reingold; N T Hargrett; K N Shands; B B Dan; G P Schmid; B Y Strickland; C V Broome
Journal:  Ann Intern Med       Date:  1982-06       Impact factor: 25.391

8.  Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases.

Authors:  K N Shands; G P Schmid; B B Dan; D Blum; R J Guidotti; N T Hargrett; R L Anderson; D L Hill; C V Broome; J D Band; D W Fraser
Journal:  N Engl J Med       Date:  1980-12-18       Impact factor: 91.245

9.  Toxic-shock syndrome associated with phage-group-I Staphylococci.

Authors:  J Todd; M Fishaut; F Kapral; T Welch
Journal:  Lancet       Date:  1978-11-25       Impact factor: 79.321

10.  Serologic responses to toxic shock syndrome (TSS) toxin-1 in menstrual and nonmenstrual TSS.

Authors:  P M Rosten; K H Bartlett; A W Chow
Journal:  Clin Invest Med       Date:  1988-06       Impact factor: 0.825

View more
  15 in total

1.  Application of a Chimeric Protein Construct having Enterotoxin B and Toxic Shock Syndrome Toxin Domains of S. aureus in Immunodiagnostics.

Authors:  R Shylaja; Devi Kalyan Kumar Thakasi; H S Murali; K Prakash Narayana Reddy; H V Batra
Journal:  Indian J Microbiol       Date:  2012-03-31       Impact factor: 2.461

2.  Staphylococcus aureus exotoxins are present in vivo in tampons.

Authors:  Patrick M Schlievert; Kimberly A Nemeth; Catherine C Davis; Marnie L Peterson; Bruce E Jones
Journal:  Clin Vaccine Immunol       Date:  2010-03-24

Review 3.  Device-Associated Menstrual Toxic Shock Syndrome.

Authors:  Patrick M Schlievert; Catherine C Davis
Journal:  Clin Microbiol Rev       Date:  2020-05-27       Impact factor: 26.132

4.  Persistence survey of toxic shock syndrome toxin-1 producing Staphylococcus aureus and serum antibodies to this superantigen in five groups of menstruating women.

Authors:  Jeffrey Parsonnet; Melanie A Hansmann; Jon L Seymour; Mary L Delaney; Andrea M Dubois; Paul A Modern; Michaelle B Jones; John E Wild; Andrew B Onderdonk
Journal:  BMC Infect Dis       Date:  2010-08-23       Impact factor: 3.090

5.  Inhibition of toxic shock by human monoclonal antibodies against staphylococcal enterotoxin B.

Authors:  Eileen A Larkin; Bradley G Stiles; Robert G Ulrich
Journal:  PLoS One       Date:  2010-10-11       Impact factor: 3.240

6.  The effect of vaginal microbial communities on colonization by Staphylococcus aureus with the gene for toxic shock syndrome toxin 1 (TSST-1): a case-control study.

Authors:  Jacob D Pierson; Melanie A Hansmann; Catherine C Davis; Larry J Forney
Journal:  Pathog Dis       Date:  2018-06-01       Impact factor: 3.166

7.  Superantigens subvert the neutrophil response to promote abscess formation and enhance Staphylococcus aureus survival in vivo.

Authors:  Stacey X Xu; Kevin J Gilmore; Peter A Szabo; Joseph J Zeppa; Miren L Baroja; S M Mansour Haeryfar; John K McCormick
Journal:  Infect Immun       Date:  2014-06-09       Impact factor: 3.441

8.  Diverse enterotoxin gene profiles among clonal complexes of Staphylococcus aureus isolates from the Bronx, New York.

Authors:  Avanish K Varshney; José R Mediavilla; Natalie Robiou; Alice Guh; Xiabo Wang; Philip Gialanella; Michael H Levi; Barry N Kreiswirth; Bettina C Fries
Journal:  Appl Environ Microbiol       Date:  2009-09-11       Impact factor: 4.792

Review 9.  Staphylococcal and streptococcal superantigen exotoxins.

Authors:  Adam R Spaulding; Wilmara Salgado-Pabón; Petra L Kohler; Alexander R Horswill; Donald Y M Leung; Patrick M Schlievert
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

10.  Chronic Staphylococcus aureus Superantigen Toxic Shock Syndrome Toxin-1 Exposure Accelerates the Progression of Atherosclerosis in Rabbits.

Authors:  Huanqiang Zhao; Lei Chen; Chunyan He; Shaobo Li; Han Yang; Xiaogang Xu; Fupin Hu; Zelin Cui; Qingzhong Liu
Journal:  Acta Cardiol Sin       Date:  2020-01       Impact factor: 2.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.